The FDA has approved Jazz Pharmaceuticals’ sleep disorder drug Xywav, to treat daytime sleepiness in patients with narcolepsy, offering a regime with less sodium than standard therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback